Home » Topics » BioWorld Science

BioWorld Science
RSS

Amgen patents short transient receptor potential channel 6 antagonists

May 13, 2019

New broad spectrum antivirals discovered at FORGE Life Science

May 13, 2019

Polyphor temporarily halts enrollment in phase III studies of murepavadin

May 13, 2019

Gene editing restores skin functionality in blistering disease

May 13, 2019

SHR-1210 plus capecitabine and oxaliplatin shows promising safety and efficacy in GC/GEJ

May 13, 2019

Investigators present phase II data for CBT-001 for the treatment of pterygia

May 13, 2019

AAI 2019: T-cell therapy could be brought within reach of "virtually all" patients

May 13, 2019

LY-3154207 demonstrates linear plasma PK and promising safety in healthy volunteers

May 13, 2019

Merck & Co. discovers dual TBK1/IKBKE inhibitors

May 13, 2019

NIH initiates LATITUDE study to evaluate long-acting HIV medication

May 13, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...